HopeStage
Back to all studies
CompletedNCT06874374

Individualized Non-invasive Brain Stimulation for the Treatment of Major Depressive Disorder

Device studyAges 18–70United StatesDepression
The study in practice

Understand this study

Who was this study for?

This study was for people with depression. Listed age limits: 18 years to 70 years. Other eligibility criteria applied.

Listed locations
Chapel HillSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: April 11, 2025
Recruitment status
Completed
Enrollment listed in the registry
40
Sponsor
Pulvinar Neuro, LLC
Sponsor type
Other organization
Study type
Device
Intervention type
Device
Locations
United States
Age range
From 18 Years to 70 Years
Official registry ID
NCT06874374
Official title
Show the full official title

Closed-Loop Transcranial Alternating Current Stimulation (CL-tACS) for the Treatment of Major Depressive Disorder: Double-Blind, Sham-Controlled Randomized Pilot Study

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Chapel Hill

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Pulvinar Neuro, LLC.

Who was this study for?

This study was for people with depression. Listed age limits: 18 years to 70 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies